ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Tango Therapeutics Inc

Tango Therapeutics Inc (TNGX)

2.73
-0.30
(-9.90%)
At close: February 10 4:00PM
2.79
0.06
( 2.20% )
After Hours: 4:31PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
2.79
Bid
2.70
Ask
2.79
Volume
616,440
2.72 Day's Range 3.06
2.585 52 Week Range 12.80
Market Cap
Previous Close
3.03
Open
3.06
Last Trade
11
@
2.79
Last Trade Time
16:36:55
Financial Volume
$ 1,760,488
VWAP
2.8559
Average Volume (3m)
1,128,578
Shares Outstanding
107,417,818
Dividend Yield
-
PE Ratio
-2.90
Earnings Per Share (EPS)
-0.95
Revenue
36.53M
Net Profit
-101.74M

About Tango Therapeutics Inc

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Tango Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TNGX. The last closing price for Tango Therapeutics was $3.03. Over the last year, Tango Therapeutics shares have traded in a share price range of $ 2.585 to $ 12.80.

Tango Therapeutics currently has 107,417,818 shares outstanding. The market capitalization of Tango Therapeutics is $325.48 million. Tango Therapeutics has a price to earnings ratio (PE ratio) of -2.90.

TNGX Latest News

Tango Therapeutics to Present at the Guggenheim SMID Cap Biotechnology Conference

BOSTON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision...

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...

Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.12-4.123711340212.913.412.7255049463.14804345CS
4-0.18-6.060606060612.973.412.5856216272.98074117CS
12-1.03-26.96335078533.824.222.58511285783.28398809CS
26-5.75-67.33021077288.5412.0152.58514122015.04784867CS
52-9.87-77.962085308112.6612.82.58510447146.31165798CS
156-6.18-68.89632107028.9713.032.477432926.96677105CS
260-6.82-70.96774193559.6118.842.476624637.20328722CS

TNGX - Frequently Asked Questions (FAQ)

What is the current Tango Therapeutics share price?
The current share price of Tango Therapeutics is $ 2.79
How many Tango Therapeutics shares are in issue?
Tango Therapeutics has 107,417,818 shares in issue
What is the market cap of Tango Therapeutics?
The market capitalisation of Tango Therapeutics is USD 325.48M
What is the 1 year trading range for Tango Therapeutics share price?
Tango Therapeutics has traded in the range of $ 2.585 to $ 12.80 during the past year
What is the PE ratio of Tango Therapeutics?
The price to earnings ratio of Tango Therapeutics is -2.9
What is the cash to sales ratio of Tango Therapeutics?
The cash to sales ratio of Tango Therapeutics is 8.09
What is the reporting currency for Tango Therapeutics?
Tango Therapeutics reports financial results in USD
What is the latest annual turnover for Tango Therapeutics?
The latest annual turnover of Tango Therapeutics is USD 36.53M
What is the latest annual profit for Tango Therapeutics?
The latest annual profit of Tango Therapeutics is USD -101.74M
What is the registered address of Tango Therapeutics?
The registered address for Tango Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Tango Therapeutics website address?
The website address for Tango Therapeutics is www.tangotx.com
Which industry sector does Tango Therapeutics operate in?
Tango Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
OCEAOcean Biomedical Inc
$ 0.1787
(20.74%)
11.32M
LSCCLattice Semiconductor Corp
$ 60.00
(10.15%)
627.87k
NAYANAYA Biosciences Inc
$ 0.432
(9.59%)
9.8k
BZAIBlaize Holdings Inc
$ 3.75
(9.01%)
13.54k
FTELFitell Corporation
$ 2.31
(7.44%)
9.95k
HLITHarmonic Inc
$ 7.62
(-31.47%)
441.2k
FLNCFluence Energy Inc
$ 9.94
(-23.95%)
31k
PETSPetMed Express Inc
$ 4.40
(-16.51%)
27.02k
KRKR36Kr Holdings Inc
$ 4.30
(-11.34%)
15.91k
BNAIBrand Engagement Network Inc
$ 0.621
(-10.66%)
577.42k
CYNCYNGN Inc
$ 0.19
(2.87%)
55.04M
WINTWindtree Therapeutics Inc
$ 0.1289
(-8.84%)
15.71M
ADTXAditxt Inc
$ 0.1012
(-3.25%)
13.88M
OCEAOcean Biomedical Inc
$ 0.1789
(20.88%)
11.31M
MGOLMGO Global Inc
$ 0.6564
(-6.17%)
4.88M